RNPC3 and central nervous system cancer: The in vivo BBB permeability and intracranial glioma targeting ability of ANC@RNP was then assessed by i.v. injection of 1.5 mg kg−1 equivalent AF647‐labeled RNP in orthotopic U87MG‐Luc‐bearing nude mice (Figure 3b).